EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Candida and Candidiasis: The Cell Wall as a Potential Molecular Target for Antifungal Therapy

Daniel Gozalbo, Patricia Roig, Eva Villamón, María Luisa Gil

Current Drug Target -Infectious Disorders · 01.06.2004 · 4 (2) · 117-135

DOI: 10.2174/1568005043341046 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Drug Target -Infectious Disorders, erschienen am 01.06.2004. Verfasst von Daniel Gozalbo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departament de Microbiologia i Ecologia, Facultat de Farmàcia, Universitat de València, Burjassot, Spain. daniel.gozalbo@uv.es. Die Arbeit wurde bisher 57-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The fungal species Candida albicans is an opportunistic pathogen, which causes serious infections in humans, particularly in immunocompromised patients. Depending on the underlying host defect, C. albicans causes a variety of infections, ranging from superficial mucocutaneous candidiasis to life-threatening disseminated infections. Both the limited spectrum of antifungal drugs currently in clinical use and the emergence of resistances make necessary the development of new effective antifungal drugs with minimal side effects; however, such a research is limited by the small number of specific target sites identified to date. The cell wall is a fungal specific dynamic structure essential to almost every aspect of the biology and pathogenicity of C. albicans. Its structure confers physical protection and shape to fungal cells, and as the most external part of the fungus, the cell wall mediates the interaction with the host, including adhesion to host tissues and modulation of the host anti-Candida immune response. Consequently, the fungal cell wall can be considered as a suitable target for development of new antifungal compounds. Therefore two distinct types of potential cell wall-related targets can be envisaged, according to their mode of action in inhibiting infection: (i) inhibition of cell wall biogenesis, which may impair cell wall integrity and thus cell viability, and (ii) modification of host-fungus interactions by inhibiting or blocking putative virulence factors, which may impair host colonization and progress of the infectious process. Antibodies specific to cell wall antigens may protect against infection by a variety of mechanisms and may evolve into save antifungal agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsCandidaCandidiasisCell WallDrug Delivery SystemsDrug DesignDrug Resistance, FungalHumansImmunotherapy

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Departament de Microbiologia i Ecologia, Facultat de Farmàcia, Universitat de València, Burjassot, Spain. daniel.gozalbo@uv.es

Zitieren

APA

Gozalbo, D., Roig, P., Villamón, E., & Gil, M. L. (2004). Candida and Candidiasis: The Cell Wall as a Potential Molecular Target for Antifungal Therapy. Current Drug Target -Infectious Disorders, 4(2), 117-135. https://doi.org/10.2174/1568005043341046

Vancouver

Gozalbo D, Roig P, Villamón E, Gil ML. Candida and Candidiasis: The Cell Wall as a Potential Molecular Target for Antifungal Therapy. Current Drug Target -Infectious Disorders. 2004;4(2):117-135. doi:10.2174/1568005043341046

BibTeX
@article{Gozalbo2004,
  author = {Gozalbo, Daniel and Roig, Patricia and Villamón, Eva and Gil, María Luisa},
  title = {Candida and Candidiasis: The Cell Wall as a Potential Molecular Target for Antifungal Therapy},
  journal = {Current Drug Target -Infectious Disorders},
  year = {2004},
  volume = {4},
  number = {2},
  pages = {117--135},
  doi = {10.2174/1568005043341046}
}
Kostenlos starten →